Hipra mycoplasma vaccine

Pd9338

Hipra's mypravac suis vaccine is for the prevention of respiratory disease due to Mycoplasma hyopneumoniae. It protects from the first week of life to the end of grow-finishing. The vaccine presents a new combination of adjuvants based on levamisole and carbomer, offering higher and longer-lasting immunity while avoiding adverse reactions since it is non-oil based. Administration is also improved.